{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:26:00Z","timestamp":1764739560606,"version":"3.46.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The mechanisms underlying the clinical effect of Deep Brain Stimulation (DBS) for Parkinson\u2019s disease (PD) remain debated. Proton magnetic resonance spectroscopy (\n                      <jats:sup>1<\/jats:sup>\n                      H-MRS) provides a biochemical non-invasive\n                      <jats:italic>in vivo<\/jats:italic>\n                      insight. This article aims to increase the understanding of advanced PD pathophysiology and DBS using MRS before and after surgery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Eleven PD patients and seven healthy controls were included. Preoperatively and approximately 7\u202fmonths postoperatively, single-voxel MRS using a PRESS sequence was performed on a 1.5\u202fT (tesla) system. Voxels were placed bilaterally in the thalamus (14\u202f\u00d7\u202f13\u202f\u00d7\u202f13\u202fmm\n                      <jats:sup>3<\/jats:sup>\n                      ) and the lentiform nucleus (15\u202f\u00d7\u202f13\u202f\u00d7\u202f12\u202fmm\n                      <jats:sup>3<\/jats:sup>\n                      ). Metabolite concentrations of total N-acetylaspartate\u202f+\u202fN-acetyl-aspartyl-glutamate (tNA), total creatine\u202f+\u202fphosphocreatine (tCr), total choline\u202f+\u202fphosphocholine\u202f+\u202fglycerophosphocholine (tCho), and total glutamate and glutamine, which together constitute Glx were quantified. To assess treatment outcomes following surgery, medications were converted to levodopa equivalent doses (LED) using a standardized conversion formula, both pre- and post-DBS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 11 patients, with a mean PD duration of 9.4\u202fyears, were implanted with bilateral implantation (22 leads). All patients self-reported relief of symptoms and significantly reduced their medication (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), with a calculated preoperative LED of 925\u202f\u00b1\u202f272 and a postoperative LED of 611\u202f\u00b1\u202f210 (mean\u202f\u00b1\u202fSD), representing a 32% reduction after surgery. The patients, prior to surgery, compared to a healthy control group, showed no differences in the resulting metabolite concentrations (tCr, tNA, tCho, Glx) in voxels placed in the thalamus and lentiform nucleus. However, thalamic tNA concentrations differed significantly following DBS targeting the subthalamic nucleus (STN), both in comparison to healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.02) and relative to preoperative concentrations within the patient group (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.03). No furher resulting concentrations differed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We present novel metabolite observations obtained through MRS in this exploratory study. Thalamic tNA concentrations in PD patients were comparable to those of healthy controls prior to surgery, but were significantly reduced following DBS implantation targeting the STN. These findings suggests the presence of a metabolite thalamic effect associated with DBS treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1662142","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:20:53Z","timestamp":1764739253000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Thalamic metabolite changes after subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease: an exploratory magnetic resonance spectroscopy study"],"prefix":"10.3389","volume":"16","author":[{"given":"Nathanael","family":"G\u00f6ransson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Tapper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Zsigmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Tisell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/joim.13541","article-title":"Deep brain stimulation for Parkinson's disease","volume":"292","author":"Hariz","year":"2022","journal-title":"J Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/ane.12733","article-title":"Algorithms for the treatment of motor problems in Parkinson's disease","volume":"136","author":"Dietrichs","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0140-6736(95)90062-4","article-title":"Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation","volume":"345","author":"Limousin","year":"1995","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N Engl J Med"},{"key":"ref7","first-page":"344","article-title":"Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease","volume":"50","author":"Benabid","year":"1987","journal-title":"Appl Neurophysiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.nurt.2008.01.010","article-title":"Mechanisms and targets of deep brain stimulation in movement disorders","volume":"5","author":"Johnson","year":"2008","journal-title":"Neurotherapeutics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1093\/brain\/awad239","article-title":"Neurophysiological mechanisms of deep brain stimulation across spatiotemporal resolutions","volume":"146","author":"Neumann","year":"2023","journal-title":"Brain J Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/1073858415581986","article-title":"Mechanism of deep brain stimulation: inhibition, excitation, or disruption?","volume":"22","author":"Chiken","year":"2016","journal-title":"Neuroscientist"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s13311-016-0426-6","article-title":"Deep brain stimulation for movement disorders of basal ganglia origin: restoring function or functionality?","volume":"13","author":"Wichmann","year":"2016","journal-title":"Neurotherapeutics"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/mds.22120","article-title":"Latest view on the mechanism of action of deep brain stimulation","volume":"23","author":"Hammond","year":"2008","journal-title":"Mov Disord"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00415-019-09486-8","article-title":"Zona incerta as a therapeutic target in Parkinson's disease","volume":"267","author":"Ossowska","year":"2020","journal-title":"J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp-2017-317219","article-title":"Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation","volume":"89","author":"Blomstedt","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1602\/neurorx.2.2.197","article-title":"Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making","volume":"2","author":"Lin","year":"2005","journal-title":"NeuroRx"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1148\/radiol.13130531","article-title":"Clinical proton MR spectroscopy in central nervous system disorders","volume":"270","author":"Oz","year":"2014","journal-title":"Radiology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","article-title":"A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra","volume":"39","author":"Rae","year":"2014","journal-title":"Neurochem Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1523\/JNEUROSCI.13-03-00981.1993","article-title":"Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types","volume":"13","author":"Urenjak","year":"1993","journal-title":"J Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1212\/01.wnl.0000311267.63292.6c","article-title":"N-acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance","volume":"70","author":"Benarroch","year":"2008","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"519816","DOI":"10.1155\/2014\/519816","article-title":"Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?","volume":"2014","author":"Ciurleo","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1468-1331.2000.00111.x","article-title":"Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy","volume":"7","author":"Clarke","year":"2000","journal-title":"Eur J Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ana.410370211","article-title":"Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy","volume":"37","author":"Davie","year":"1995","journal-title":"Ann Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/brain\/120.9.1541","article-title":"Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration","volume":"120","author":"Tedeschi","year":"1997","journal-title":"Brain J Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mds.870120306","article-title":"Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy","volume":"12","author":"Clarke","year":"1997","journal-title":"Mov Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/nbm.1141","article-title":"Glutamate measurement in Parkinson's disease using MRS at 3 T field strength","volume":"20","author":"Kickler","year":"2007","journal-title":"NMR Biomed"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.parkreldis.2017.07.028","article-title":"Thalamic neurometabolic alterations in tremulous Parkinson's disease: a preliminary proton MR spectroscopy study","volume":"43","author":"Barbagallo","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0730-725X(97)00079-9","article-title":"Proton MR spectroscopic imaging of the striatum in Parkinson's disease","volume":"15","author":"Cruz","year":"1997","journal-title":"Magn Reson Imaging"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1544688","DOI":"10.3389\/fneur.2025.1544688","article-title":"Metabolic alterations in patients with essential tremor before and after deep brain stimulation: keys to understanding tremor using magnetic resonance spectroscopy","volume":"16","author":"Goransson","year":"2025","journal-title":"Front Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"Levodopa dose equivalency in Parkinson's disease: updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov Disord"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000511406","article-title":"Postoperative Lead movement after deep brain stimulation surgery and the change of stimulation volume","volume":"99","author":"G\u00f6ransson","year":"2021","journal-title":"Stereotact Funct Neurosurg"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/mrm.24554","article-title":"Procedure for quantitative (1)H magnetic resonance spectroscopy and tissue characterization of human brain tissue based on the use of quantitative magnetic resonance imaging","volume":"70","author":"Tisell","year":"2013","journal-title":"Magn Reson Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41531-021-00223-5","article-title":"Subthalamic and pallidal deep brain stimulation for Parkinson's disease-meta-analysis of outcomes","volume":"7","author":"Lachenmayer","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.parkreldis.2007.08.009","article-title":"1H-MRS experiences after bilateral DBS of the STN in Parkinson's disease","volume":"14","author":"Llumiguano","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/mrm.1910330502","article-title":"Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study","volume":"33","author":"Holshouser","year":"1995","journal-title":"Magn Reson Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e3895","DOI":"10.1002\/nbm.3895","article-title":"Chasing N-acetyl-L-aspartate, a shiny NMR object in the brain","volume":"31","author":"Baslow","year":"2018","journal-title":"NMR Biomed"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0306-4522(91)90101-S","article-title":"Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies","volume":"45","author":"Simmons","year":"1991","journal-title":"Neuroscience"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/ana.102","article-title":"Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy?","volume":"49","author":"Martin","year":"2001","journal-title":"Ann Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.mri.2015.10.038","article-title":"Investigation of NAA and NAAG dynamics underlying visual stimulation using MEGA-PRESS in a functional MRS experiment","volume":"34","author":"Landim","year":"2016","journal-title":"Magn Reson Imaging"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/brain\/117.1.49","article-title":"Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions","volume":"117","author":"Davie","year":"1994","journal-title":"Brain"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.410400215","article-title":"Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging","volume":"40","author":"Hugg","year":"1996","journal-title":"Ann Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1212\/WNL.49.2.438","article-title":"Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study","volume":"49","author":"Ellis","year":"1997","journal-title":"Neurology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1468-1331.2006.01569.x","article-title":"Chronic subthalamic high-frequency deep brain stimulation in Parkinson's disease--a histopathological study","volume":"14","author":"Nielsen","year":"2007","journal-title":"Eur J Neurol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.4172\/2168-975X.1000169","article-title":"Influence on deep brain stimulation from lead design, operating mode and tissue impedance changes - a simulation study","volume":"4","author":"Alonso","year":"2015","journal-title":"Brain Disord Therapy"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1662142\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:20:54Z","timestamp":1764739254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1662142\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":43,"alternative-id":["10.3389\/fneur.2025.1662142"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1662142","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"article-number":"1662142"}}